Skip to main content

Advertisement

SpringerLink
Log in

Role and differential expression of calpastatin mRNA and protein in cultured cardiomyocytes exposed to hypoxic stress

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We previously proposed that the calpain-mediated proteolytic pathway is activated in cultured cardiomyocytes following exposure to hypoxia (Mol Cell Biochem 214: 47, 2000). The potential role of calpastatin, the endogenous specific inhibitor of calpain, and its expression in the hypoxic state were investigated here. Hypoxia induced the expression of two calpastatin and multiple VEGF splice variants. Although cardiomyocytes and fibroblasts responded to hypoxia differentially, both cell types exhibited hypoxia-induced calpastatin transcription. The two functional calpastatin splice variants encoding the 593- and 654-amino acid calpastatin isoforms differed only in their N-terminal leader domain sequences. In spite of the increased mRNA expression, levels of the calpastatin protein doublet were not increased, but rather slightly decreased under the hypoxic condition. Cardiac hypoxia was accompanied by preferential proteolytic cleavage of troponin I (TnI), one of the major myofibrillar proteins. Forced expression of calpastatin through an adenoviral vector effectively prevented the hypoxia- and calpain-mediated TnI proteolysis. Our results highlight the discordant expression pattern of cardiac calpastatin mRNA and protein in the hypoxic state. We suggest that although induction of calpastatin gene transcription may constitute a compensatory mechanism coping with the hypoxic stress, a sustained high calpastatin protein level appears to be essential in the intervention of the activated calpain proteolytic cascade. (Mol Cell Biochem 265: 63–70, 2004)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nayler WG: The role of calcium in the ischemic myocardium. Am J Pathol 102: 262–270, 1981

    Google Scholar 

  2. Ver Donck L, Borgers M, Verdonck F: Inhibition of sodium and calcium overload pathology in the myocardium: A new cytoprotective principle. Cardiovasc Res 27: 349–357, 1993

    Google Scholar 

  3. Atsma DE, Bastiaanse EM, Jerzewski A, Van der Valk LJ, Van der Laarse A: Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ Res 76: 1071–1078, 1995

    Google Scholar 

  4. Kositprapa C, Zhang B, Berger S, Canty JMJ, Lee TC: Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes. Mol Cell Biochem 214: 47–55, 2000

    Google Scholar 

  5. Ganote C, Armstrong S: Ischaemia and the myocyte cytoskeleton: Re-view and speculation. Cardiovasc Res 27: 1387–1403, 1993

    Google Scholar 

  6. McDonough JL, Arrell DK, Van Eyk JE: Troponin I degrada-tion and covalent complex formation accompanies myocardial is-chemia/ reperfusion injury. Circ Res 84: 9–20, 1999

    Google Scholar 

  7. Blomgren K, McRae A, Bona E, Saido TC, Karlsson J-O, Hagberg H: Degradation of fodrin and MAP2 after neonatal cerebral hypoxic-ischemia. Brain Res 684: 136–142, 1995

    Google Scholar 

  8. Blomgren K, Hallin U, Andersson AL, Puke-Sundvall M, Bahr BA, McRae A, Saido TC, Kawashima S, Hagberg H: Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem 274: 14046–14052, 1999

    Google Scholar 

  9. Wang KKW, Yuen P-W: Calpain inhibition: An overview of its thera-peutic potential. Trends Pharmacol Sci 15: 412–419, 1994

    Google Scholar 

  10. Squier MK, Miller AC, Malkinson AM, Cohen JJ: Calpain activation in apoptosis. J Cell Physiol 159: 229–237, 1994

    Google Scholar 

  11. Badalamente MA, Stracher A: Delay of muscle degeneration and necro-sis in mdx mice by calpain inhibition. Muscle Nerve 23: 106–111, 2000

    Google Scholar 

  12. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, Li Z, Powers JC: Calpain as a novel target for treating acute neurode-generative disorders. Neurol Res 17: 249–258, 1995

    Google Scholar 

  13. Schoenwaelder SM, Burridge K: Evidence for a calpeptin-sensitive protein-tyrosine phosphatase upstream of the small GTPase Rho. J Biol Chem 274: 14359–14367, 1999

    Google Scholar 

  14. Melloni E, Salamino F, Sparatore B: The calpain-calpastatin system in mammalian cells: Properties and possible functions. Biochimie 74: 217–223, 1992

    Google Scholar 

  15. Goll DE, Thompson VF, Li H, Wei W, Cong J: The calpain system. Physiol Rev 83: 731–801, 2003

    Google Scholar 

  16. Nishimura T, Goll DE: Binding of calpain fragments to calpastatin. J Biol Chem 266: 11842–11850, 1991

    Google Scholar 

  17. Nakamura M, Inomata M, Imajoh S, Suzuki K, Kawashima S: Fragmen-tation of an endogenous inhibitor upon complex formation with high-and low-calcium-requiring forms of calcium-activated neutral proteases. Biochemistry 28: 449–455, 1989

    Google Scholar 

  18. Takano E, Ueda M, Tsunekawa S, Murakami T, Maki M, Hatanaka M, Murachi T: Molecular diversity of erythrocyte calpastatin. Biomed Biochim Acta 50: 517–521, 1991

    Google Scholar 

  19. Takano E, Maki M, Mori H, Hatanaka M, Marti T, Titani K, Kannagi R, Ooi T, Murachi T: Pig heart calpastatin: Identification of repetitive domain structures and anomalous behavior in polyacrylamide gel elec-trophoresis. Biochemistry 27: 1964, 1988

    Google Scholar 

  20. Ishida S, Emori Y, Suzuki K: Rat calpastatin has diverged primary se-quence from other mammalian calpastatins but retains functionally im-portant sequences. Biochim Biophys Acta 1088: 436–438, 1991

    Google Scholar 

  21. Lee WJ, Hatanaka M, Maki M: Multiple forms of rat calpastatin cDNA in the coding region of functionally unknown amino-terminal domain. Biochim Biophys Acta 1129: 251–253, 1992

    Google Scholar 

  22. Takano J, Watanabe M, Hitomi K, Maki M: Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by al-ternative first exons and differentially expressed in mouse tissues. J Biochem 128: 83–92, 2000

    Google Scholar 

  23. De Tullio R, Sparatore B, Salamino F, Melloni E, Pontremoli S: Rat brain contains multiple mRNAs for calpastatin. FEBS Lett 422: 113–117, 1998

    Google Scholar 

  24. Adachi Y, Ishida-Takahashi A, Takahashi C, Takano E, Murachi T, Hatanaka M: Phosphorylation and subcellular distribution of calpastatin in human hematopoietic system cells. J Biol Chem 266: 3968–3972, 1991

    Google Scholar 

  25. Cong M, Thompson VF, Goll DE, Antin PB: The bovine calpastatin gene promoter and a new N-terminal region of the protein are targets for cAMP-dependent protein kinase activity. J Biol Chem 273: 660–666, 1998

    Google Scholar 

  26. Chen SJ, Bradley ME, Lee TC: Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: Modulation by calcium-regulated proteases and protein kinases. Mol Cell Biochem 178: 141–149, 1998

    Google Scholar 

  27. Walowitz JL, Bradley ME, Chen SJ, Lee TC: Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. J Biol Chem 273: 6656–6661, 1998

    Google Scholar 

  28. Sabath DE, Broome HE, Prystowsky MB: Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 91: 185–191, 1990

    Google Scholar 

  29. Guillemin K, Krasnow MA: The hypoxic response: Huffing and HIFing. Cell 89: 9–12, 1997

    Google Scholar 

  30. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32A: 2413–2422, 1996

    Google Scholar 

  31. Asada K, Ishino Y, Shimada M, Shimojo T, Endo M, Kimizuka F, Kato I, Maki M, Hatanaka M, Murachi T: A cloning of human calpastatin: structural comparison between human, pig, and rabbit calpastatins. J Enzyme Inhibition 3: 49–56, 1989

    Google Scholar 

  32. Borger DR, Essig DA: Induction of HSP 32 gene in hypoxic cardiomy-ocytes is attenuated by treatment with N-acetyl-L-cysteine. AmJ Physiol 274: H965–H973, 1998

    Google Scholar 

  33. Lee PJ, Jiang B-H, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AMK: Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375–5381, 1997

    Google Scholar 

  34. Wang GL, Jiang B-H, Rue EA, Semenza GL: Hypoxia-inducible fac-tor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular oxygen tension. Proc Natl Acad Sci USA 92: 5510–5514, 1995

    Google Scholar 

  35. De Tullio R, Averna M, Salamino F, Pontremoli S, Melloni E: Differen-tial degradation of calpastatin by mu-and m-calpain in calcium-enriched human neuroblastoma LAN-5 cells. FEBS Lett 475: 17–21, 2000

    Google Scholar 

  36. Barnoy S, Supino-Rosin L, Kosower NS: Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability. Biochem J 351: 413–420, 2000

    Google Scholar 

  37. Salamino F, De Tullio R, Michetti M, Mengotti P, Melloni E, Pontremoli S: Modulation of calpastatin specificity in rat tissues by reversible phos-phorylation and dephosphorylation. Biochem Biophys Res Commun 199: 1326–1332, 1994

    Google Scholar 

  38. Averna M, De Tullio R, Passalacqua M, Salamino F, Pontremoli S, Melloni E: Changes in intracellular calpastatin localization are mediated by reversible phosphorylation. Biochem J 354: 25–30, 2001

    Google Scholar 

  39. Doumit ME, Koohmaraie M: Immunoblot analysis of calpastatin degra-dation: evidence for cleavage by calpain in postmortem muscle. J Anim Sci 77: 1467–1473, 1999

    Google Scholar 

  40. Wang KKW, Posmantur R, Nadimpalli R: Caspase-mediated fragmen-tation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 356: 187–196, 1998

    Google Scholar 

  41. Mellgren RL, Mericle MT, Lane RD: Proteolysis of the calcium-dependent protease inhibitor by myocardial calcium-dependent pro-tease. Arch Biochem Biophys 246: 233–239, 1986

    Google Scholar 

  42. Nagao S, Saido TC, Akita Y, Tsuchiya T, Suzuki K, Kawashima S: Calpain-calpastatin interactions in epidermoid carcinoma KB cells. J Biochem 115: 1178–1184, 1994

    Google Scholar 

  43. Hall E, Lockley AK, Parr T, Bardsley RG: Interaction of calpastatin isoforms with L-type calcium channels. Biochem Soc Trans 26: S307, 1998

    Google Scholar 

  44. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, Marban E: Transgenic mouse model of stunned my-ocardium. Science 287: 488–491, 2000

    Google Scholar 

  45. Huang X, Pi Y, Lee KJ, Henkel AS, Gregg RG, Powers PA, Walker, JW: Cardiac troponin I gene knockout. A mouse model of myocardial troponin I deficiency. Circ Res 84: 1–8, 1999

    Google Scholar 

  46. Tidball JG, Spencer MJ: Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 545: 819–828, 2002

    Google Scholar 

  47. Perez-Pinzon MA, Mumford PL, Carranza V, Sick TJ: Calcium influx from the extracellular space promotes NADH hyperoxidation and elec-trical dysfunction after anoxia in hippocampal slices. J Cereb Blood Flow Metab 18: 215–221, 1998

    Google Scholar 

  48. Schafer M, Bahde D, Bosche B, Ladilov Y, Schafer C, Piper HM, Noll T: Modulation of early [Ca2+]i rise in metabolically inhibited endothelial cells by xestospongin C. Am J Physiol Heart Circ Physiol 280: H1002–H1010, 2001

    Google Scholar 

  49. Spencer MJ, Mellgren RL: Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 11: 2645–2655, 2002

    Google Scholar 

  50. Costelli P, Tullio RD, Baccino FM, Melloni E: Activation of calcium-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer 84: 946–950, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Center for Research in Cardiovascular Medicine, State University of New York, Buffalo, NY, USA

    Huey Lin, Milish P. Risbood, Atul Jain, Victor Vacanti & Techung Lee

Authors
  1. Huey Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milish P. Risbood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atul Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Victor Vacanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Techung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, H., Risbood, M.P., Jain, A. et al. Role and differential expression of calpastatin mRNA and protein in cultured cardiomyocytes exposed to hypoxic stress. Mol Cell Biochem 265, 63–70 (2004). https://doi.org/10.1023/B:MCBI.0000044316.04876.6f

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000044316.04876.6f

Search

Navigation